Capricor Therapeutics Inc
F:4LN2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capricor Therapeutics Inc
F:4LN2
|
US |
|
A
|
Atrys Health SA
F:A2T
|
ES |
|
B
|
Barton Gold Holdings Ltd
ASX:BGD
|
AU |
|
L
|
Lloyds Banking Group PLC
SWB:LLD
|
UK |
|
A
|
Adforus Co Ltd
KOSDAQ:397810
|
KR |
|
M
|
Marie Brizard Wine and Spirits SA
SWB:BED
|
FR |
|
A
|
Albis Leasing AG
XMUN:ALG
|
DE |
|
D
|
Descartes Systems Group Inc
F:DC2
|
CA |
|
K
|
Kawasaki Heavy Industries Ltd
DUS:KHE
|
JP |
|
I
|
Indexa Capital Group SA
MAD:INDXA
|
ES |
|
GNI Group Ltd
F:3G6
|
JP |
|
C
|
Compass Group PLC
OTC:CMPGF
|
UK |
|
Kobe Bussan Co Ltd
OTC:KOBCY
|
JP |
|
Discovery Ltd
OTC:DCYHF
|
ZA |
|
PAMT Corp
NASDAQ:PAMT
|
US |
|
Schaeffler AG
OTC:SCAFF
|
DE |
|
T3 Defense Inc
NASDAQ:DFNS
|
US |
|
Corbion NV
AEX:CRBN
|
NL |
|
Z
|
Zhejiang Expressway Co Ltd
XMUN:ZHJ
|
CN |
|
V
|
Venator Materials PLC
OTC:VNTRF
|
UK |
|
U
|
U-Tech Co Ltd
KOSDAQ:178780
|
KR |
|
W
|
Wallbridge Mining Company Ltd
F:WC7
|
CA |
|
Z
|
Zurich Insurance Group AG
XHAM:ZFIN
|
CH |
|
Kbc Groep NV
F:KDB
|
BE |
Bankruptcy Probability
Capricor Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Capricor Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
333.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
506.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
196.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
131.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
79.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Capricor Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Capricor Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.